[Leg blood flow in reactive hyperaemia (author's transl)].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Linhart.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The changes in blood flow through selected brain structures and the changes in the total RNA content of cells of these structures were examined after a single administration of yeast RNA to 6-month-old male rats. The total content of ribosomal RNA in cells of the limbic system (septum, hippocampus, hypothalamus) increased 48 hrs after the administration of 100 mg i.p. yeast RNA , dropped after 7 days (in hypothalamus), 21 and 30 days (in hippocampus), 30 days (in septum). In cells of the limbic system as a whole there is a higher total RNA content in experimental rats. No changes were observed in the cells of parietal brain cortex. Blood flow increased in limbic structures 21 and 30 days after RNA administration and in septum and in hippocampus also 90 days after application. No changes were observed in parietal brain cortex, bulbi olfactorii, cerebellum and brain stem. Histochemical changes correlated positively with blood flow changes in the limbic system 14, 21, 30 and 90 days after RNA application. The body weight of experimental rats did not differ from that of control animals. The changes in haemodynamic parameters were transient and were demonstrated as fluctuations in heart rate, cardiac output, and peripheral resistance. Blood pressure experienced no changes.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The study was aimed at evaluating the effect of pyridinolcarbamate in patients with atherosclerosis obliterans of the lower limbs. A single intravenous administration of the drug did not induce changes in resting blood flow, but elicited a significant decline in capillary filtration rate. In a double-blind cross-over trial patients reported a significant prolongation of walking distance after 6 months of pyridinolcarbamate treatment. Sensation of cold in the lower limbs was not affected. Pyridinolcarbamate did not influence peak values of blood flow through the calf but they appeared significantly earlier. No significant changes were seen at the evaluation of the elevation and dependency test and performance using tiptoeing test. Likewise the findings of systolic pressure in the lower limbs, pulse wave morphology, and claudication distance on treadmill did not confirm a therapeutic effect of pyridinolcarbamate.
Three weeks of ischemia of the right hind limb in rat produced by ligature and severing of the right common iliac artery, resulted in changes in FFA transport and blood flow in the regenerating tibialis muscle. FFA transport was measured using i.v. administered palmitate-1-14C bound to albumin. Uptake of palmitate-1-14C or 86Rb 90 s after i.v. administration was decreased in ischemic tibialis muscle, whereas no apparent effect of ischemia on the contralateral muscle was seen. Plasma FFA outflow rate measured according Beker and Rostami was not affected by the presence of an ischemic extremity in comparison with control animals. The plasma FFA inflow rate into the ischemic muscle was markedly decreased to values of 6.5 mmumoles FFA/min/g whereas in control animals values were 18.8 mmumoles FFA/min/g wet tissue. Decreased FFA inflow rate to the ischemic tibialis muscle was due to the decreased radioactivity of palmitate-1-14C in the muscle under the conditions of a constant plasma FFA pool. Differences in the uptake of palmitate-1-14C in tibialis muscle were dependent upon the muscle blood flow, which was markedly decreased in the ischemic muscle on indirect measurement with 86Rb or with the 133Xe clearance.
Explore the source record for details and available documents.